Diversity of extended-spectrum β-lactamase-producing Enterobacteriaceae on hospital admission

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 3, 2012, Pages 231-236

  Roux, Damien ^a,b,c   Huy, Clarisse ^b   Lolom, Isabelle ^b   Andremont, Antoine ^b,c   Arlet, Guillaume ^d   Armand Lefevre, Laurence ^b   Lucet, Jean Christophe ^b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Hosp University Bichat C Bernard   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

lactamases; Community acquired infections; Enterobacterial isolates; Epidemiology; Risk factors

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; COTRIMOXAZOLE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; CITROBACTER KOSERI; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HOSPITAL ADMISSION; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; DNA, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84857543052     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.623314     Document Type: Article

References (20)

1. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005;18:657-86.
2. Arlet G, Rouveau M, Casin I, Bouvet PJ, Lagrange PH, Philippon A. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals. J Clin Microbiol 1994;32:2553-8. (Pubitemid 24284663)
3. Canton R, Oliver A, Coque TM, Varela MdC, Perez-Diaz JC, Baquero F. Epidemiology of extended-spectrum betalactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period. J Clin Microbiol 2002;40:1237-43. (Pubitemid 34279882)
4. Pitout JD, Laupland KB. Extended-spectrum β -lactamaseproducing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8:159-66. (Pubitemid 351249250)
5. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, et al. Infl ux of extended-spectrum beta-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 2006;42:925-34.
6. Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004;42:1089-94. (Pubitemid 38332830)
7. Paterson DL. Resistance in Gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 2006;34:S20-8; discussion S64-73.
8. Talbot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006;42:657-68. (Pubitemid 43271379)
9. Lucet JC, Decre D, Fichelle A, Joly-Guillou ML, Pernet M, Deblangy C, et al. Control of a prolonged outbreak of extended-spectrum beta-lactamase- producing Enterobacteriaceae in a university hospital. Clin Infect Dis 1999;29: 1411-8. (Pubitemid 30022733)
10. McCabe R, Reid WM, Knox WG. Evaluation of the use of a temporary percutaneous endotracheal catheter in the treatment and prevention of postoperative pulmonary complications. Ann Surg 1962;156:5-8.
11. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE - acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 1981;9:591-7.
12. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, et al. Dissemination of CTX-M-type betalactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 2004;48: 1249-55. (Pubitemid 38405479)
13. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007;59:165-74. (Pubitemid 47072053)
14. Rodriguez-Bano J, Alcala JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, et al. Community infections caused by extended-spectrum beta-lactamase- producing Escherichia coli. Arch Intern Med 2008;168:1897-902.
15. Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, Perea EJ, Perez-Cano R, et al. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 2006;42: 37-45. (Pubitemid 41832077)
16. Arslan H, Azap OK, Ergonul O, Timurkaynak F. Risk factors for ciprofl oxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 2005;56:914-8. (Pubitemid 41631917)
17. Cattoir V, Nordmann P. Plasmid-mediated quinolone resistance in Gram-negative bacterial species: an update. Curr Med Chem 2009;16:1028-46.
18. Rodriguez-Bano J, Picon E, Gijon P, Hernandez JR, Ruiz M, Pena C, et al. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 2010;50:40-8.
19. Marcade G, Deschamps C, Boyd A, Gautier V, Picard B, Branger C, et al. Replicon typing of plasmids in Escherichia coli producing extended-spectrum beta-lactamases. J Antimicrob Chemother 2009;63:67-71.
20. Kola A, Holst M, Chaberny IF, Ziesing S, Suerbaum S, Gastmeier P. Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period. J Hosp Infect 2007; 66:46-51. (Pubitemid 46657123)